Nazaire-Bermal, N.; Jia, N.; Maronilla, M.A.C.; Lopez, J.F.; Zeng, G.; Wu, W.; Nimo, A.B.C.; Luan, C.; Xin, Q.
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial. Vaccines 2025, 13, 973.
https://doi.org/10.3390/vaccines13090973
AMA Style
Nazaire-Bermal N, Jia N, Maronilla MAC, Lopez JF, Zeng G, Wu W, Nimo ABC, Luan C, Xin Q.
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial. Vaccines. 2025; 13(9):973.
https://doi.org/10.3390/vaccines13090973
Chicago/Turabian Style
Nazaire-Bermal, Nancy, Ningning Jia, Maria Angela C. Maronilla, Josemaria F. Lopez, Gang Zeng, Wenbin Wu, Adrielle Bernice C. Nimo, Chunfang Luan, and Qianqian Xin.
2025. "Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial" Vaccines 13, no. 9: 973.
https://doi.org/10.3390/vaccines13090973
APA Style
Nazaire-Bermal, N., Jia, N., Maronilla, M. A. C., Lopez, J. F., Zeng, G., Wu, W., Nimo, A. B. C., Luan, C., & Xin, Q.
(2025). Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial. Vaccines, 13(9), 973.
https://doi.org/10.3390/vaccines13090973
